What happens when you take phenytoin with enteral feeding?
Phenytoin (Dilantin, Phenytek) is an anti-seizure medicine that has to stay inside a fairly narrow blood-level range to work. Enteral feeding means liquid nutrition given through a tube into the stomach or small intestine, often in hospital, in rehabilitation or at home after a stroke, brain injury or swallowing problem. When oral phenytoin is given with these formulas, much less of it may reach the bloodstream.
- Phenytoin given by mouth or by tube has to be absorbed from the gut.
- When a feeding formula is in the gut at the same time, phenytoin absorption can drop sharply. Researchers have suggested binding to formula proteins or other ingredients, but the exact cause is still unknown.
- With less phenytoin absorbed, blood levels can fall well below the range that controls seizures.
- When the feeds stop, absorption recovers and levels climb back up, and they could go higher than intended if the dose was raised in the meantime.
The phenytoin label says that patients who receive enteral feeding preparations and related nutritional supplements have had lower than expected phenytoin levels, and suggests that phenytoin not be given at the same time as an enteral feed.
Why is this important?
The size of the drop in some patients is large. In the best-known study, levels fell to roughly a quarter of their previous value within a week of starting continuous tube feeds. Levels that low can leave a person unprotected against seizures.
People who need tube feeding are often the ones who can least afford a seizure: people recovering from brain surgery, head injury, stroke or status epilepticus. A review of the evidence concluded that lower phenytoin levels during enteral feeding may increase the risk of seizures.
The effect also works in reverse. If the phenytoin dose is raised to make up for the feeds, and the feeds are later stopped or changed, levels could rise too high. The phenytoin label lists unsteadiness, slurred speech, sleepiness and confusion among its dose-related side effects.
What should you do?
Most of the decisions here belong to the care team, but patients and family caregivers can help make sure nothing is missed.
When tube feeding starts: Make sure every prescriber and the pharmacist know that the person takes phenytoin. Ask how the feeds and the phenytoin will be timed, since the label advises against giving them together.
While feeds continue: Phenytoin levels may need to be checked more often, as the label suggests. Report any seizure, or any new unsteadiness, slurred speech or confusion, right away.
When feeds change or stop: Tell the prescriber before or as soon as the feeding plan changes, including a switch of formula, a move from continuous to bolus feeds, or a return to eating by mouth. Levels may shift again.
Pausing feeds for a short time around each dose is used in some hospitals, but the evidence is mixed: one early nursing study found that stopping feeds for two hours before and after each dose did not raise levels. Do not change the feeding schedule or the phenytoin dose on your own.
Which specific products are affected?
On the medication side, this applies to oral phenytoin given by mouth or through a feeding tube: Dilantin extended capsules, Dilantin-125 oral suspension, Dilantin Infatabs, Phenytek and generic phenytoin products. Phenytoin or fosphenytoin given into a vein does not pass through the gut, so the feeding formula does not affect its absorption.
On the nutrition side, the label covers enteral feeding preparations and related nutritional supplements. That includes standard and specialized tube-feeding formulas, given continuously or in bolus feeds. In one study, healthy people who simply drank a tube-feeding formula alongside phenytoin also had lower levels, so oral nutrition shakes taken at the same time as phenytoin are worth asking your pharmacist about.
The science behind it
The Dilantin prescribing information (section 7.4) states that patients receiving enteral feeding preparations and related nutritional supplements have had lower than expected phenytoin levels, suggests not giving phenytoin with an enteral feed, and says more frequent level monitoring may be needed.
Bauer LA (Neurology. 1982; PMID 6803191) studied 20 neurosurgery patients and 5 healthy subjects. In 10 patients on continuous nasogastric feeds, the mean phenytoin level was 2.59 micrograms per mL and rose to 10.22 within 7 days of stopping the feeds. In 10 other patients, the mean level fell from 9.80 to 2.72 within 7 days of starting feeds. In the healthy subjects, drinking the feeding formula with a single dose lowered phenytoin levels by an average of 71.6%.
A systematic review by Au Yeung SC and Ensom MH (Ann Pharmacother. 2000; PMID 10928402) found that four randomized controlled trials in healthy volunteers did not show the interaction, while many reports in patients showed dramatic drops. The authors concluded that the evidence supports the interaction in patients, that its mechanism is unknown, and that no single accepted way to prevent it exists. Case reports, such as two children with status epilepticus whose levels reached range only when feeds stopped or the drug was given by vein (O'Hagan M, Wallace SJ. Brain Dev. 1994; PMID 8048710), point the same way. On mechanism, a lab study in intestinal cells found that casein, a milk protein common in formulas, bound phenytoin and lowered its passage through the cell layer, as did digested soy protein and dextrin (Urashima Y, et al. JPEN J Parenter Enteral Nutr. 2023; PMID 37376765). That is a cell study, not proof of the cause in people.
What was not settled: the best timing strategy. Ozuna J and Friel P (J Neurosurg Nurs. 1984; PMID 6438282) found that holding feeds for two hours before and after each dose was not effective in their patients. Holding guidelines are still used in some hospitals, and a 2023 study of one such guideline found it did not reduce how much of their daily nutrition goal patients reached (Webb AJ, et al. Nutr Clin Pract. 2023; PMID 37537901).
Frequently Asked Questions
Why would a feeding tube change how phenytoin works?
Phenytoin given through the tube still has to be absorbed from the gut. When feeding formula is there at the same time, much less phenytoin may be absorbed. The exact reason is not known.
Does stopping the feed for a couple of hours around each dose fix it?
Not reliably. One study found a two-hour pause before and after each dose did not raise levels. Some hospitals still use pauses, together with level checks, so follow the care team's plan.
What should I watch for in a family member on tube feeds and phenytoin?
Seizures are the main concern if levels drop. If levels run high, look for unsteadiness, abnormal eye movements, slurred speech, unusual sleepiness or confusion. Report either to the care team promptly.
Do nutrition shakes I drink count too?
Possibly. The label mentions related nutritional supplements, and healthy people who drank a tube-feeding formula with phenytoin had lower levels. Ask your pharmacist whether to take phenytoin apart from a nutrition shake.
What happens when the tube feeding stops?
Absorption recovers and levels rise, possibly above range if the dose was raised during feeding. That is why the prescriber should know before the feeding plan changes.
Key takeaways
- Enteral feeding formulas can sharply lower the absorption of oral phenytoin.
- In one study, levels fell to about a quarter of their usual value within a week of starting continuous feeds.
- The phenytoin label advises against giving phenytoin with an enteral feed and suggests more frequent level checks.
- A short pause in feeds around each dose did not reliably fix the problem in one study.
- Tell the care team whenever tube feeding starts, changes or stops; never change the phenytoin dose or feeding plan on your own.
